Researchers uncover a human-specific enhancer that influences brain size in transgenic mice.
A pair of studies examines interbreeding between Neanderthals and modern human ancestors.
Budget cuts and other changes may be leading young Australian researchers to seek positions outside the country.
In Science this week: ancient genetic mutations linked to Gleevec activity, and more.
A study finds that one article has been cited more than two dozen times since its retraction.
Rhodes College's Loretta Jackson-Hayes argues that more STEM majors with liberal arts backgrounds are needed.
Researchers report in NEJM that the order in which mutations accumulate in cancer may affect disease path.
In Nature this week: the Roadmap Epigenomics Program publishes numerous studies examining the human epigenome.
MIT's Technology Review puts the 'Internet of DNA' on its list of breakthroughs to watch.
Researchers are looking through well-preserved remains of cholera victims in an abandoned Italian cemetery for Vibrio cholerae DNA.
The Mason lab responds to some criticism of its recent subway metagenome paper.
In Nucleic Acids Research this week: methylation patterns in pediatric B-ALL, approach to analyze copy number variants from whole exome data, and more.
Abigail Zuger at the New York Times' Well blog notes that many chronic diseases have lifestyle and environmental factors in addition to genetic ones that may confound precision medicine approaches.
The Financial Times' Henny Sender writes that BGI is a new kind of Chinese technology company.
In PNAS this week: rare variants linked to bipolar disorder, advent of polyploidy, and more.
Under the right conditions, data stored in DNA could last millions of years, Swiss researchers say.
A device under development at Harvard and MIT aims to diagnose infectious diseases at the point of care.
Some Chinese scientists working abroad are returning to China to start their own companies, Reuters reports.
In PLOS this week: genomic characterization of "super-shedder" Escherichia coli strain, genetic divergence in parapatric stickleback populations, and more.
A Forbes article says that better coordination between regulators, as well as more accelerated approvals of certain drugs will be critical to the success of Obama's precision medicine initiative.
The tech giant has introduced a new feature to its search results to provide "high-quality medical data."
NIH and HHS are seeking changes to the clinical trials reporting process, including changes to all NIH-funded trials, even if they are not currently subject to a federal law.
In Science this week, HCV RNA replication, and a strategy for identifying functional centromeric sequences.
A simulation shows that small biases can affect the funding rate of non-preferred class investigators.
Lawmakers in the US introduce a bill to make National Institutes of Health funding non-discretionary.